Ohr Pharmaceutical Issues Letter to Shareholders

News | 31 July 2012

NEW YORK, NY, Jul 31, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. (OBB:OHRP) , a pharmaceutical company dedicated to developing novel treatments for large unmet medical needs, issued the following letter to shareholders today: ...

Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)